Anti-Human CD45 eFluor® 450

Also known as: LCA

Clone: 2D1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 48-9459

Cat. No. Size
48-9459-41 25 tests
48-9459-42 100 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human CD45 eFluor® 450 (Pacific Blue® replacement) .

Staining of normal human peripheral blood cells with Mouse IgG1 kappa Isotype Control eFluor® 450...View More

  • Data for Anti-Human CD45 eFluor® 450 (Pacific Blue® replacement) .
Description

Description: The 2D1 monoclonal antibody reacts with all isoforms of human CD45, also known as Leukocyte Common Antigen (LCA). CD45 is expressed by all hematopoietic cells excluding circulating erythrocytes and platelets. The cytoplasmic portion of CD45 has tyrosine phosphatase enzymatic activity and plays an important role in activation of lymphocytes.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate eFluor 450
Laser Violet Laser
Emit 450 nm
Excite 405 nm
Reported Applications Flow Cytometric Analysis
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
12-9459 Anti-Human CD45 PE 488 - 561 nm 575 nm FC RUO
17-9459 Anti-Human CD45 APC 633 - 647 nm 660 nm FC RUO
11-9459 Anti-Human CD45 FITC 488 nm 518 nm FC RUO
45-9459 Anti-Human CD45 PerCP-Cy5.5 488 nm 690 nm FC RUO
References

References: Bradstock K.F., Janossy G., Pizzolo G., Hoffbrand A.V., McMichael A., Pilch J.R., Milstein C., Beverley P., Bollum F.J. Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst. 1980 Jul; 65(1):33-42.

Tchilian E.Z., Wallace D.L., Wells R.S., Flower D.R., Morgan G., Beverley P.C. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol. 2001 Jan 15;166(2):1308-13.